Fig. 5From: Novel organoid construction strategy for non-involuting congenital hemangioma for drug validation (A) NICH organoid seed in plates and ten days of cells derived from its organoid. (B) Bright field image, (C) VE-Cadherin in green and DAPI in blue, (D) Vimentin in red and DAPI in blue. Scale bar = 100 μmBack to article page